Mechanism by Which Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure and Possible Differences in Heart Failure Risk

Journal of Cardiology - Japan
doi 10.1016/j.jjcc.2018.07.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Resistin, Adiponectin, and Risk of Heart Failure

Journal of the American College of Cardiology
Cardiovascular MedicineCardiology
2009English

Is Risk-Benefit of Warfarin for Atrial Fibrillation With Heart Failure Determined by Heart Failure Severity?

Thrombosis and Haemostasis
Hematology
2015English

Risk Stratification in Acute Heart Failure: Reply

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Risk Scores in End Stage Heart Failure

Cardiologia Croatica
Cardiovascular MedicineCardiology
2014English

Ethnic Differences in Heart Failure

Heart Lung and Circulation
Respiratory MedicinePulmonaryCardiovascular MedicineCardiology
2019English

Risk-Treatment Mismatch in the Pharmacotherapy of Heart Failure

JAMA - Journal of the American Medical Association
Medicine
2005English

Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

Heart Failure and the Risk of Stroke: The Rotterdam Study

European Journal of Epidemiology
Epidemiology
2010English

The Risk of Venous Thromboembolism in Patients With Heart Failure

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy